Cello Group PLC operates in the Commercial nonphysical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cello Group PLC with three other
miscellaneous service companies in Europe:
Bachem Holding AG
sales of 208.60 million Swiss Francs [US$210.71 million]
of which 84%
was Active Pharmaceutical Ingredients),
(£168.40 million [US$207.13 million]
of which 43%
was Huntsworth Health), and
Hoegh LNG Holdings Ltd
based in Norway
(1.61 billion Norwegian Kroner [US$197.67 million]
of which 69%
Cello Group PLC reported sales of £157.32 million (US$193.50 million)
December of 2015.
decrease of 7.4%
versus 2014, when the company's sales were £169.87 million.
Contributing to the drop in overall sales was the 66.1% decline
in Unallocated Corporate Expenses, from £2.93 million to £994,000.00 .
There were also decreases in sales in
Cello Signal (down 14.9% to £92.77 million)
However, these declines were partially offset by the increase in sales of
Cello Health (up 9.7% to £63.55 million)